Трансабдоминальное ультразвуковое исследование в диагностике и динамическом наблюдении пациента с язвенным колитом (клиническое наблюдение)

На клиническом примере продемонстрированы возможности трансабдоминального ультразвукового исследования толстой кишки в диагностике и динамическом наблюдении у пациента с язвенным колитом. Показано, что трансабдоминальное ультразвуковое исследование, выполняемое в серошкальном режиме с использованием допплерографии в режиме цветового допплеровского картирования, позволяет мониторировать степень разрешения воспаления в слизистой оболочке толстой кишки, а также оценивать эффективность консервативной терапии.

1. Клинические рекомендации. Язвенный колит. 2020 (22.07.2020). Утверждены Минздравом РФ, 56 с. Интернет-ссылка: http://disuria.ru/load/zakonodatelstvo/klinicheskie_rekomendacii_protokoly_lechenija/54.

2. Du L, Ha C. Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterol Clin North Am. 2020 Dec;49(4):643-654. DOI: 10.1016/j.gtc.2020.07.005. Epub 2020 Sep 25. PMID: 33121686.

3. Greuter T, Vavricka SR. Extraintestinal manifestations in inflammatory bowel disease - epidemiology, genetics, and pathogenesis. Expert Rev Gastroenterol Hepatol. 2019 Apr;13(4):307-317. DOI: 10.1080/17474124.2019.1574569. Epub 2019 Feb 20. PMID: 30791773.

4. Younis N, Zarif R, Mahfouz R. Inflammatory bowel disease: between genetics and microbiota. Mol Biol Rep. 2020 Apr;47(4):3053-3063. DOI: 10.1007/s11033-020-05318-5. Epub 2020 Feb 21. PMID: 32086718.

5. Луговкина А.А., Рудакова Л.О., Крюкова Н.А., Бессонов А.А., и соавт. Особенности диагностики и лечения неспецифического язвенного колита. Экспериментальная и клиническая гастроэнтерология. 2019;164(4): 10–16.

6. Magro F, Gionchetti P, Eliakim R, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J CrohnsColitis. 2017; 11: 649–670.

7. Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology. 2021; 160: 1570–1583.

8. Ungaro R, Colombel JF, Lissoos T, et al. A treat-to-target update in ulcerative colitis: a systematic review. Am J Gastroenterol. 2019; 114: 874–883.

9. Bezzio C, Schettino M, Manes G, et al. Tolerability of bowel preparation and colonoscopy in IBD patients: results from a prospective, single-center, case–control study. Crohns Colitis. 360 2020; 2: 1–6.

10. Bryant RV, Friedman AB, Wright EK, et al. Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application. Gut. 2018; 67: 973–985.

11. De Voogd F, Wilkens R, Gecse K, et al. A reliability study – strong inter-observer agreement of an expert panel for intestinal ultrasound in ulcerative colitis. J Crohns Colitis. 2021; 15: 1284–1290.

12. Bots S, Nylund K, Löwenberg M, et al. Ultrasound for assessing disease activity in IBD patients: a systematic review of activity scores. J Crohns Colitis. 2018; 12: 920–929.

13. Smith RL, Taylor KM, Friedman AB, et al. Systematic review: clinical utility of gastrointestinal ultrasound in the diagnosis, assessment and management of patients with ulcerative colitis. J Crohns Colitis. 2020; 14: 465–479.

14. Kucharzik T, Maaser C and MacOni G. Do we need activity scores or simply clear criteria for intestinal ultrasound in ulcerative colitis? J Crohns Colitis. 2018; 12: 1383–1384.

15. Pascu M, Roznowski AB, Müller HP, et al. Clinical relevance of transabdominal ultrasonography and magnetic resonance imaging in patients with inflammatory bowel disease of the terminal ileum and large bowel. Inflamm Bowel Dis. 2004; 10: 373–382.

16. Allocca M, Fiorino G, Bonovas S, et al. Accuracy of Humanitas Ultrasound Criteria in assessing disease activity and severity in ulcerative colitis: a prospective study. J Crohns Colitis. 2018; 12: 1385–1391.

17. Antonelli E, Giuliano V, Casella G, et al. Ultrasonographic assessment of colonic wall in moderate-severe ulcerative colitis: comparison with endoscopic findings. Dig Liver Dis. 2011; 43: 703–706.

18. Parente F, Greco S, Molteni M, et al. Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel. Aliment Pharmacol Ther. 2003; 18: 1009–1016.

19. Maaser C, Petersen F, Helwig U, et al. Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis: results from the TRUST&UC study. Gut. 2020; 69: 1629–1636.

20. Sagami S, Kobayashi T, Miyatani Y, et al. Accuracy of ultrasound for evaluation of colorectal segments in patients with inflammatory bowel diseases: a systematic review and metaanalysis. Clin Gastroenterol Hepatol. 2021; 19: 908–921.

21. Buisson A, Gonzalez F, Poullenot F, et al. Comparative acceptability and perceived clinical utility of monitoring tools: a nationwide survey of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2017; 23: 1425–1433.

22. Bezzio C and Saibeni S. Gastrointestinal ultrasound in inflammatory bowel disease: seeing beyond limits. Dig Liver Dis. 2020; 52: 19–20.